MCW Cardiovascular Center Faculty & Labs

Faculty and labs included on this page are currently housed in the Cardiovascular Center.

Researcher surveying samples in refrigeration

CVC Members

See the Faculty Collaboration Database for a complete list of all Cardiovascular Center Members – principal investigators and affiliated faculty.


John A. Auchampach, PhD

John Auchampach, PhD, a professor in Pharmacology, has an NIH-funded laboratory focuses on ischemic heart disease, cardiac regeneration, and drug development.


Ivor Benjamin, MD, FAHA, FACC

Ivor J. Benjamin MD, FAHA, FACC, is a board-certified specialist and consultant in internal medicine and cardiology. His clinical interests are general cardiology, inheritable heart failure, and myocardial infarction.


Andreas M. Beyer, PhD

The Beyer lab investigates the contribution of mitochondrial defects to development of microvascular defects in multiple disease phenotypes. Specific projects include understanding the underlying mechanism that contribute to coronary artery disease (CAD) and the role of microvascular (dys)function in chemotherapy induced cardiovascular events (Cardio Oncology).


Matt Durand, PhD

Assistant Professor, Physical Medicine and Rehabilitation


Carol Everson, PhD

Professor, Department of Medicine


Julie Freed, MD, PhD

Dr. Julie Freed researches sphingolipids in the development of endothelial dysfunction in the human microcirculation. Elevated plasma levels of ceramide, a prototypical sphingolipid, is now considered an independent risk factor for major adverse cardiovascular events in otherwise healthy people.

Aron Geurts, PhD

Aron Geurts, PhD

Aron Geurts, PhD, MCW Professor, leads an NIH-funded research team focused on innovating novel approaches to genetic engineering.


Caitlin O'Meara, PhD

Associate Professor, Physiology

Michaela Patterson, PhD

Michaela Patterson, PhD
Assistant Professor, Cell Biology, Neurobiology and Anatomy

The Patterson Lab seeks to understand the genetic, molecular and cellular processes that allow for endogenous heart cells, cardiomyocytes, to re-enter the cell cycle and regenerate lost cardiac muscle tissue.


Kevin R. Regner, MD, MS, FASN

The Kevin Regner laboratory investigates the cellular, molecular, and genetic mechanisms involved in ischemic acute kidney injury (AKI) and kidney repair.

Mary Sorci-Thomas, PhD

Mary Sorci-Thomas, PhD

Dr. Sorci-Thomas's research focuses on the molecular mechanisms involved in high density lipoprotein apoA-I-mediated protection against the progression of human disease.


Michael E. Widlansky, MD, MPH

Dr. Michael E. Widlansky's human vascular research laboratory has been formed to foster collaboration with investigators from other disciplines interested in the impact of vascular function on disease states relevant to their fields of interest.


David X. Zhang, PhD

The overall emphasis of Dr. Zhang’s research is to understand signaling mechanisms in regulation of blood vessel reactivity and homeostasis under normal states as well as in diseases such as coronary artery disease (CAD), hypertension, and diabetes. The current research is focused on the vascular regulation by ion channels such as transient receptor potential (TRP) channels and K+ channels.